Development and Validation of a Rapid LC–MS/MS Method for the Quantification of Contezolid in Human Plasma and Liver, and Its Application to a Pharmacokinetic Study in Liver Transplant Patients
Biomedical Chromatography · 2026
DOI: 10.1002/bmc.70369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2026. Verfasst von Zhuoran Tian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Liver Transplantation, Liquid Chromatography-Mass Spectrometry, Liver. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Zhejiang Provincial Natural Science Foundation, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
A rapid and reliable liquid chromatography–tandem mass spectrometry (LC–MS/MS) method was established for the quantification of contezolid in human plasma and liver tissue. Sample preparation was performed by protein precipitation using linezolid as the internal standard. Chromatographic separation was achieved on an ACQUITY BEH C18 column (2.1 × 50 mm, 1.8 μm) with a mobile phase consisting of 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B), delivered at a flow rate of 0.5 mL/min. Quantification was performed in multiple reaction monitoring (MRM) mode, monitoring the transitions m/z 409.1 → 269.1 for contezolid and m/z 338.1 → 296.2 for linezolid. The method showed excellent linearity over the ranges of 20–10,000 ng/mL in plasma and 100–50,000 ng/g in liver tissue. Full validation confirmed that the method met regulatory standards for accuracy, precision, sensitivity, selectivity, stability, matrix effects, carryover, and interference. The validated assay was successfully applied to a pharmacokinetic study of contezolid in liver transplant recipients. In conclusion, this robust, efficient, and cost‐effective LC–MS/MS method provides a valuable tool for the determination of contezolid in clinical and pharmacokinetic research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
- Department of Hepatobiliary Pancreatic Surgery, Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan (Hangzhou) Hospital, Shulan International Medical College, Zhejiang Shuren Univ…
ORCID-Profile: Xingxing Diao
Förderung
- Zhejiang Provincial Natural Science Foundation
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Tian, Z., Zhong, S., Wei, H., Pan, A., Zhu, H., Zhu, D., Lu, J., Yu, J., Diao, X., & Zhuang, L. (2026). Development and Validation of a Rapid LC–MS/MS Method for the Quantification of Contezolid in Human Plasma and Liver, and Its Application to a Pharmacokinetic Study in Liver Transplant Patients. Biomedical Chromatography. https://doi.org/10.1002/bmc.70369
Vancouver
Tian Z, Zhong S, Wei H, Pan A, Zhu H, Zhu D, et al. Development and Validation of a Rapid LC–MS/MS Method for the Quantification of Contezolid in Human Plasma and Liver, and Its Application to a Pharmacokinetic Study in Liver Transplant Patients. Biomedical Chromatography. 2026. doi:10.1002/bmc.70369
BibTeX
@article{Tian2026,
author = {Tian, Zhuoran and Zhong, Siyi and Wei, Huimin and Pan, Anni and Zhu, Hengkai and Zhu, Dan and Lu, Jianfang and Yu, Jinghua and Diao, Xingxing and Zhuang, Li},
title = {Development and Validation of a Rapid LC–MS/MS Method for the Quantification of Contezolid in Human Plasma and Liver, and Its Application to a Pharmacokinetic Study in Liver Transplant Patients},
journal = {Biomedical Chromatography},
year = {2026},
doi = {10.1002/bmc.70369}
}
EUVIMED